Relationship Between High Circulating Adiponectin With Bone Mineral Density and Bone Metabolism in Elderly Males With Chronic Heart Failure

Journal of Cardiac Failure

Volumn 16, Issue 4, 2010, Pages 301-307

  Bozic, Biljana ^a,b   Loncar, Goran ^c   Prodanovic, Nenad ^a   Radojicic, Zoran ^b   Cvorovic, Vojkan ^d   Dimkovic, Sinisa ^c   Popovic Brkic, Vera ^d  

^a UNIVERSITY OF DEFENCE   (Serbia)

^b UNIVERSITY OF BELGRADE   (Serbia)

^c Clinical Centre Zvezdara   (Serbia)

^d CLINICAL CENTER OF SERBIA   (Serbia)

Author keywords

Adiponectin; bone; bone markers; heart failure; leptin

Indexed keywords

ADIPONECTIN; CALCIFEDIOL; LEPTIN; OSTEOCALCIN; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; PARATHYROID HORMONE; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

AGED; ARTICLE; BODY COMPOSITION; BONE DENSITY; BONE MASS; BONE METABOLISM; BONE MINERAL; CONTROLLED STUDY; DISEASE SEVERITY; DUAL ENERGY X RAY ABSORPTIOMETRY; ECHOCARDIOGRAPHY; GRIP STRENGTH; HEART FAILURE; HIP; HUMAN; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADIPONECTIN; AGED; BIOLOGICAL MARKERS; BONE AND BONES; BONE DENSITY; CHRONIC DISEASE; HEART FAILURE; HUMANS; LEPTIN; LUMBAR VERTEBRAE; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS;

EID: 77950034070     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2009.12.015     Document Type: Article

References (37)

1. Braunwald E. Biomarkers in heart failure. N Engl J Med 358 (2008) 2148-2159
2. Okamoto H. Can adiponectin be a novel metabolic biomarker for heart failure?. Circ J 73 (2009) 1012-1013
3. Kenny A.M., Boxer R., Walsh S., and Hager W.D. Femoral bone mineral density in patients with heart failure. Osteoporos Int 17 (2006) 1420-1427
4. Anker S.D., Clark A.L., Teixeira M.M., Hellewell P.G., and Coats A.J. Loss of bone mineral in patients with cachexia due to chronic heart failure. Am J Cardiol 83 (1999) 612-615
5. Zittermann A., Schleithoff S.S., and Koerfer R. Markers of bone metabolism in congestive heart failure. Clin Chim Acta 366 (2006) 27-36
6. Khosla S., Atkinson E.J., Riggs B.L., and Melton L.J. Relationship between body composition and bone mass in women. J Bone Miner Res 11 (1996) 857-863
7. Reid I.R. Relationships among body mass, its components, and bone. Bone 31 (2002) 547-555
8. Luo X.H., Guo L.J., Yuan L.Q., Xie H., Zhou H.D., Wu X.P., et al. Adiponectin stimulates human osteoblasts proliferation and differentiation via the MAPK signaling pathway. Exp Cell Res 309 (2005) 99-109
9. Luo X.H., Guo L.J., Xie H., Yuan L.Q., Wu X.P., Zhou H.D., et al. Adiponectin stimulates RANKL and inhibits OPG expression in human osteoblasts through the MAPK signaling pathway. J Bone Miner Res 21 (2006) 1648-1656
10. Ealey K.N., Kaludjerovic J., Archer M.C., and Ward W.E. Adiponectin is a negative regulator of bone mineral and bone strenght in growing mice. Exp Biol Med (Maywood) 233 (2008) 1546-1553
11. Lenchik L., Register T.C., Hsu F.C., Lohman K., Nicklas B.J., Freedman B.I., et al. Adiponectin as a novel determinant of bone mineral density and visceral fat. Bone 33 (2003) 646-651
12. Basurto L., Galván R., Cordova N., Saucedo R., Vargas C., Campos S., et al. Adiponectin is associated with low bone mineral density in elderly men. Eur J Endocrinol 160 (2009) 289-293
13. Oh K.W., Lee W.Y., Rhee E.J., Baek K.H., Yoon K.H., Kang M.I., et al. The relationship between serum resistin, leptin, adiponectin, ghrelin levels and bone mineral density in middle-aged men. Clin Endocrinol (Oxf) 63 (2005) 131-138
14. Gonnelli S., Caffarelli C., Del Santo K., Cadirini A., Guerriero C., Lucani B., et al. The relationship of ghrelin and adiponectin with bone mineral density and bone turnover markers in elderly man. Calcif Tissue Int 19 (2008) 55-60
15. Hamrick M.W., and Ferrari S.L. Leptin and the sympathetic connection of fat to bone. Osteoporos Int 19 (2008) 905-912
16. Kontogianni M.D., Dafni U.G., Routsias J.G., and Skopouli F.N. Blood leptin and adiponectin as possible mediators of the relation between fat mass and BMD in perimenopausal women. J Bone Miner Res 19 (2004) 546-551
17. Martini G., Valenti R., Giovani S., Franci B., Campagna S., and Nuti R. Influence of insulin-like growth factor-1 and leptin on bone mass in healthy postmenopausal women. Bone 28 (2001) 113-117
18. Anker S.D., Ponikowski P., Varney S., Chua T.P., Clark A.L., Webb-Peploe K.M., et al. Wasting as independent risk factor for mortality in chronic heart failure. Lancet 349 (1997) 1050-1053
19. The Criteria Committee of the New York Heart Association Criteria for diagnosis and treatment of heart failure (1994), Little, Brown and Company, Boston, MA
20. ATS statement: guidelines for the six-minute walk test. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. Am J Respir Crit Care Med 166 (2002) 111-117
21. Silvestry F.E., Kerber R.E., Brook M.M., Carroll J.D., Eberman K.M., Goldstein S.A., et al. Echocardiography-guided interventions. J Am Soc Echocardiogr 22 (2009) 213-231
22. Tamura T., Furukawa Y., Taniguchi R., Sato Y., Ono K., Horiuchi H., et al. Serum adiponectin level as an independent predictor of mortality in patients with congestive heart failure. Circ J 71 (2007) 623-630
23. George J., Patal S., Wexler D., Sharabi Y., Peleg E., Kamari Y., et al. Circulating adiponectin concentrations in patients with congestive heart failure. Heart 92 (2006) 1420-1424
24. Jankowska E.A., Jakubaszko J., Cwynar A., Majda J., Ponikowska B., Kustrzycka-Kratochwil D., et al. Bone mineral status and bone loss over time in men with chronic systolic heart failure and their clinical and hormonal determinants. Eur J Heart Fail 11 (2009) 28-38
25. Peng X.D., Xie H., Zhao Q., Wu X.P., Sun Z.Q., and Liao E.Y. Relationships between serum adiponectin, leptin, resistin, visfatin levels and bone mineral density, and bone biochemical markers in Chinese men. Clin Chim Acta 387 (2008) 31-35
26. Confavreux C.B., Levine R., and Karsent G. A paradigm of integrative physiology, the crosstalk between bone and energy metabolisms. Mol Cell Endocrinol 310 (2009) 21-29
27. Lee N.K., Sowa H., Hinoi E., Ferron M., Ahn J.D., Confavreux C., et al. Endocrine regulation of energy metabolism by the skeleton. Cell 130 (2007) 456-469
28. Gannagé-Yared M.H., Fares F., Semaan M., Khalife S., and Jambart S. Circulating osteoprotegerin is correlated with lipid profile, insulin sensitivity, adiponectin and sex steroids in an ageing male population. Clin Endocrinol (Oxf) 64 (2006) 652-658
29. Ducy P., Amling M., Takeda S., Priemel M., Schilling A.F., Beil F.T., et al. Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass. Cell 100 (2000) 197-207
30. Burguera B., Hofbauer L.C., Thomas T., Gori F., Evans G.L., Khosla S., et al. Leptin reduces ovariectomy-induced bone loss in rats. Endocrinology 142 (2001) 3546-3553
31. Lorentzon M., Landin K., Mellström D., and Ohlsson C. Leptin is a negative independent predictor of areal BMD and cortical bone size in young adult Swedish men. J Bone Miner Res 21 (2006) 1871-1878
32. Anand I.S., Latini R., Florea V.G., Kuskowski M.A., Rector T., Masson S., et al. C-reactive protein in heart failure: prognostic value and the effect of valsartan. Circulation 112 (2005) 1428-1434
33. Lamblin N., Mouquet F., Hennache B., Dagorn J., Susen S., Bauters C., et al. High-sensitivity C-reactive protein: potential adjunct for risk stratification in patients with stable congestive heart failure. Eur Heart J 26 (2005) 2245-2250
34. Koh J.M., Khang Y.H., Jung C.H., Bae S., Kim D.J., Chung Y.E., et al. Higher circulating hsCRP levels are associated with lower bone mineral density in healthy pre- and postmenopausal women: evidence for a link between systemic inflammation and osteoporosis. Osteoporos Int 16 (2005) 1263-1271
35. Kim B.J., Yu Y.M., Kim E.N., Chung Y.E., Koh J.M., and Kim G.S. Relationship between serum hsCRP concentration and biochemical bone turnover markers in healthy pre- and postmenopausal women. Clin Endocrinol (Oxf) 67 (2007) 152-158
36. Pasco J.A., Kotowicz M.A., Henry M.J., Nicholson G.C., Spilsbury H.J., Box J.D., et al. High-sensitivity C-reactive protein and fracture risk in elderly women. JAMA 296 (2006) 1353-1355
37. Ding C., Parameswaran V., Udayan R., Burgess J., and Jones G. Circulating levels of inflammatory markers predict change in bone mineral density and resorption in older adults: a longitudinal study. J Clin Endocrinol Metab 93 (2008) 1952-1958